JUNS
NASDAQ · Pharmaceuticals
Jupiter Neurosciences Inc
$5.10
-0.53 (-9.45%)
Open$5.30
Previous Close$5.63
Day High$5.63
Day Low$4.76
52W High$1.84
52W Low$0.07
Volume—
Avg Volume6.25M
Market Cap4.24M
P/E Ratio—
EPS$-0.26
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+761.4% upside
Current
$5.10
$5.10
Target
$43.93
$43.93
$31.75
$43.93 avg
$69.04
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 469 | 1.4K | 3.89M |
| Net Income | -195,473 | -542,143 | 896.5K |
| Profit Margin | -39,655.5% | -37,672.7% | 23.1% |
| EBITDA | -201,504 | -589,919 | 1.23M |
| Free Cash Flow | — | — | 754.2K |
| Rev Growth | -67.6% | -67.6% | +2.3% |
| Debt/Equity | 0.04 | 0.04 | 0.24 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |